🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/08/2008 | 11,27 | 13,10 | 11,23 | 12,91 | +15,00% | 16,61% | 82.474 |
| 07/08/2008 | 12,91 | 13,21 | 11,04 | 11,23 | -14,04% | 16,81% | 169.437 |
| 06/08/2008 | 12,50 | 13,47 | 12,43 | 13,06 | +4,18% | 8,38% | 70.372 |
| 05/08/2008 | 13,92 | 13,96 | 12,46 | 12,54 | -8,22% | 10,75% | 125.194 |
| 04/08/2008 | 14,00 | 14,30 | 13,10 | 13,66 | -2,14% | 8,56% | 101.390 |
| 01/08/2008 | 12,13 | 14,00 | 12,13 | 13,96 | +12,01% | 15,43% | 138.606 |
| 31/07/2008 | 11,79 | 13,14 | 11,79 | 12,46 | +0,30% | 11,43% | 80.551 |
| 30/07/2008 | 12,91 | 13,10 | 12,05 | 12,43 | -2,92% | 8,12% | 100.027 |
| 29/07/2008 | 13,06 | 13,47 | 11,53 | 12,80 | -1,16% | 14,90% | 127.919 |
| 28/07/2008 | 12,91 | 13,66 | 12,76 | 12,95 | +0,00% | 6,96% | 75.101 |
| 25/07/2008 | 13,03 | 13,10 | 12,69 | 12,95 | +1,17% | 3,16% | 67.032 |
| 24/07/2008 | 12,80 | 13,33 | 12,65 | 12,80 | +0,59% | 5,26% | 62.036 |
| 23/07/2008 | 12,31 | 13,18 | 11,98 | 12,73 | -1,45% | 9,73% | 66.872 |
| 22/07/2008 | 12,43 | 12,99 | 12,39 | 12,91 | +2,99% | 4,82% | 86.802 |
| 21/07/2008 | 12,28 | 12,99 | 12,24 | 12,54 | +2,45% | 6,10% | 71.120 |
| 18/07/2008 | 12,46 | 12,69 | 11,94 | 12,24 | -1,80% | 6,01% | 60.593 |
| 17/07/2008 | 12,28 | 12,61 | 11,90 | 12,46 | +2,15% | 5,79% | 87.497 |
| 16/07/2008 | 11,94 | 12,46 | 11,42 | 12,20 | +2,84% | 8,78% | 111.542 |
| 15/07/2008 | 11,79 | 12,16 | 11,64 | 11,87 | -0,31% | 4,44% | 87.283 |
| 14/07/2008 | 11,94 | 12,16 | 11,60 | 11,90 | +0,95% | 4,70% | 60.861 |
| 11/07/2008 | 11,34 | 11,79 | 11,27 | 11,79 | +3,28% | 4,62% | 101.924 |
| 10/07/2008 | 10,85 | 11,60 | 10,85 | 11,42 | +4,81% | 6,90% | 77.665 |
| 09/07/2008 | 10,93 | 11,27 | 10,52 | 10,89 | +0,00% | 6,85% | 100.989 |
| 08/07/2008 | 9,96 | 11,08 | 9,96 | 10,89 | +9,81% | 11,28% | 120.546 |
| 07/07/2008 | 10,44 | 10,44 | 9,84 | 9,92 | -2,21% | 5,73% | 80.337 |
| 03/07/2008 | 9,99 | 10,18 | 9,99 | 10,14 | +1,50% | 1,87% | 98.237 |
| 02/07/2008 | 9,92 | 10,14 | 9,69 | 9,99 | +0,38% | 4,53% | 119.049 |
| 01/07/2008 | 9,66 | 10,22 | 9,66 | 9,96 | +2,31% | 5,81% | 107.481 |
| 30/06/2008 | 9,73 | 10,29 | 9,51 | 9,73 | +1,17% | 8,08% | 107.187 |
| 27/06/2008 | 9,54 | 10,11 | 9,51 | 9,62 | -1,53% | 6,27% | 268.315 |